当前位置:首页 - 行情中心 - 亚星化学(600319) - 财务分析 - 利润表

亚星化学

(600319)

  

流通市值:30.82亿  总市值:30.82亿
流通股本:3.88亿   总股本:3.88亿

利润表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、营业总收入641,093,053.04427,987,206.27198,954,956.86910,416,019.35
  营业收入641,093,053.04427,987,206.27198,954,956.86910,416,019.35
二、营业总成本786,488,544.34525,662,281.79245,272,170.031,053,598,025.45
  营业成本655,764,413.13435,622,114.62201,229,888.81892,050,277.01
  税金及附加5,756,343.373,968,035.322,043,111.547,737,623.43
  销售费用9,271,846.136,089,337.052,851,127.2812,313,395.15
  管理费用41,123,805.5728,444,268.7314,202,947.3856,751,761.8
  研发费用8,127,218.225,577,693.192,617,856.6410,195,182.6
  财务费用66,444,917.9245,960,832.8822,327,238.3874,549,785.46
  其中:利息费用59,205,867.7739,305,699.3819,568,168.1166,105,746.4
  其中:利息收入714,200.51302,509.23217,878.24418,688.62
三、其他经营收益
  加:投资收益-1,216,642.02-958,698.72-174,466.39-2,404,581.77
  资产处置收益---83,261.78
  资产减值损失(新)853,236.83853,236.83--8,633,060.81
  信用减值损失(新)813,736.45813,736.45--5,324,347.7
  其他收益1,350,746.42614,088.24318,555.7851,673,297.15
四、营业利润-143,594,413.62-96,352,712.72-46,173,123.78-107,787,437.45
  加:营业外收入4,067.923,200.21,2009,622,223.1
  减:营业外支出553,805.38252,906.3943,227.06161,952.25
五、利润总额-144,144,151.08-96,602,418.91-46,215,150.84-98,327,166.6
  减:所得税费用202,341.87202,341.87-422,651.04
六、净利润-144,346,492.95-96,804,760.78-46,215,150.84-98,749,817.64
(一)按经营持续性分类
  持续经营净利润-144,346,492.95-96,804,760.78-46,215,150.84-98,749,817.64
(二)按所有权归属分类
  归属于母公司股东的净利润-143,922,087.89-96,533,998.85-46,045,120.88-97,034,677.26
  少数股东损益-424,405.06-270,761.93-170,029.96-1,715,140.38
  扣除非经常损益后的净利润-143,502,693.52-95,939,499.79-46,147,000.82-155,844,999.47
七、每股收益
  (一)基本每股收益-0.37-0.25-0.12-0.25
  (二)稀释每股收益-0.37-0.25-0.12-0.25
八、其他综合收益----187,000
  归属于母公司股东的其他综合收益----187,000
九、综合收益总额-144,346,492.95-96,804,760.78-46,215,150.84-98,936,817.64
  归属于母公司股东的综合收益总额-143,922,087.89-96,533,998.85-46,045,120.88-97,221,677.26
  归属于少数股东的综合收益总额-424,405.06-270,761.93-170,029.96-1,715,140.38
公告日期2025-10-302025-08-282025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑